{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Glicerinas%20Industriales%2C%20S.A.%20de%20C.V.","name":"Glicerinas Industriales, S.A. de C.V.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T22:05:03.676Z"},"count":2,"matches":[{"id":"e90539f5751e876a","posted_date":"2024-01-23","letter_issue_date":"2024-01-16","company_name":"Glicerinas Industriales, S.A. de C.V.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/e90539f5751e876a"},{"id":"d9ba4caa8e98c32e","posted_date":"2022-06-21","letter_issue_date":"2022-06-13","company_name":"Glicerinas Industriales, S.A. de C.V.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Drug Products/Refusal/Limited Inspection","canonical_url":"https://api.morvs.ai/fda-warning/d9ba4caa8e98c32e"}]}